| Issue Date | Title | Author(s) |
| Dec-2022 | Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China | Liu, Weiping; Ji, Jie; Zou, Dehui; Cao, Yang; Xu, Yajing; Zhou, Jian; Gao, Sujun; Wang, Fengrong; Chen, Wenming; Du, Juan; Zhou, Hui; Zhou, Fuling; Shi, Jimin; Zhang, Xi; Yang, Jianmin; Jing, Hongmei; Jiang, Zhongxing; Liu, Hui; Li, Caixia; Peng, Hongling; Jiang, Songfu; Wei, Xiaolei; He, Pengcheng; Liu, Yao; Yang, Haiyan; Li, Zengjun; Huang, Xiaobing; Liu, Lin; Shen, Lijing; Liu, Chuanfang; Song, Yuqin; Qiu, Lugui; Wang, Xiaopei; Ma, Jun; Zhu, Jun |
| 15-Nov-2022 | Efficacy and Safety of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma in China | Song, Yuqin; Ying, Zhitao; Yang, Haiyan; Guo, Ye; Li, Wenyu; Zou, Dehui; Wu, Jianqiu; Tian, Alex; Huang, Tony; Zhou, Zisong; Ma, Meilin; Yang, Su; Qin, Yun; Zhu, Jun |
| 2-Nov-2023 | Indirect Comparison of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL): An Updated Analysis with Long-Term Follow up | Song, Yuqin; Zhou, Keshu; Li, Dengju; Hu, Jianda; Zou, Dehui; Gao, Sujun; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Feng, Ru; Jin, Jie; Lyu, Fangfang; Fang, Cheng; Xu, Sheng; Zhu, Jun |
| 2023 | Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma | Song, Yuqin; Zhou, Keshu; Yang, Shenmiao; Hu, Jianda; Zou, Dehui; Gao, Sujun; Pan, Ling; Wang, Tingyu; Yang, Haiyan; Zhang, Huilai; Zhou, Daobin; Ji, Jie; Xu, Wei; Feng, Ru; Jin, Jie; Lv, Fangfang; Huang, Haiwen; Fan, Xiaosi; Xu, Sheng; Zhu, Jun |
| 2023 | Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis | Song, Yuqin; Zhou, Keshu; Zou, Dehui; Li, Dengju; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Tam, Constantine S.; Simpson, David; Wang, Michael; Phillips, Tycel J.; Opat, Stephen; Fang, Cheng; Sun, Shaohui; Zhu, Jun |
| 15-Nov-2022 | Long-Term Outcomes of Second-Line Vs Later-Line Zanubrutinib Treatment in Patients with Relapsed/Refractory MCL: An Updated Pooled Analysis | Song, Yuqin; Zhou, Keshu; Zou, Dehui; Li, Dengju; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Tam, Constantine S.; Simpson, David; Wang, Michael L.; Phillips, Tycel J.; Opat, Stephen; Fang, Cheng; Sun, Shaohui; Zhu, Jun |
| 2-Nov-2023 | Phase I Clinical Study of PA3-17 Injection in Patients with Relapsed/Refractory TLymphoblastic Leukemia/Lymphoma | Hu, Lijuan; Yu, Hui; Mei, Heng; Zou, Dehui; Li, Yaqing; Liao, Danying; Liu, Wei; Xu, Yan; Zhang, Lei; Zhang, Xudong; Sun, Zhenchang; Wang, Xinhua; Wang, Min; You, Fengtao; Meng, Huimin; Wang, Tian; Zhang, Bozhen; Yang, Lin; Zhang, Mingzhi; Huang, Xiaojun |
| 15-Nov-2022 | A Phase IV, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) As a Myeloablative Conditioning Regimen in Chinese Multiple Myeloma Patients Undergoing Autologous Stem Cell | Wang, Fengrong; Cai, Zhen; Zou, Dehui; Chen, Wenming; Song, Yongping; Fu, Chengcheng; Hu, Jiong; Yang, Ting; Chen, Xinchuan; Yan, Jinsong; Liu, Kaiyan |
| 15-Nov-2022 | Preliminary Safety and Efficacy Results of EDI001: An Investigator Initiated Trial on CRISPR/Cas9-Modified Autologous CD34(+) Hematopoietic Stem and Progenitor Cells for Patients with Transfusion Dependent ss-Thalassemia | Shi, Jun; Fang, Riguo; Gao, Zhen; Shi, Zhongyu; Kuang, Zhexiang; Zhang, Yongjian; Zhang, Lele; Yang, Huihui; Zhang, Yingchi; Zou, Dehui; Fang, Liwei; Sun, Jiali; Li, Qiang; Zou, Yao; Pan, Hong; Zhao, Jingyu; Li, Liyun; Yu, Xiao; Xu, Jing; Xu, Chun; Liu, Yanjie; Wang, Weiwei; Shi, Jia; Liu, Jie; Wang, Jia; Shi, Nian; Yang, Lei; Wang, Weiqiang; Li, Suyi; Shi, Moye; Zhang, Xiaoshuang; Yuan, Pengfei; Wei, Wensheng; Wei, Dong; Cheng, Tao |
| 2018 | Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial | Song, Yuqin; Zhou, Keshu; Zou, Dehui; Zhou, Jianfeng; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Guo, Haiyi; Wang, Aihua; Hilger, James; Huang, Jane; Novotny, William; Osman, Muhtar; Zhu, Jun |
| 1-Jun-2024 | Safety and efficacy of CD7-CAR-T cell in patients with relapsed/refractory T-lymphoblastic leukemia/lymphoma: Phase I dose-escalation/dose-expansion study | Hu, Lijuan; Yu, Hui; Mei, Heng; Zou, Dehui; Li, Yaqing; Liao, Danying; Liu, Wei; Xu, Yan; Zhang, Lei; Zhang, Xudong; Sun, Zhenchang; Wang, Xinhua; Wang, Min; You, Fengtao; Meng, Huimin; Wang, Tian; Zhang, Bozhen; Yang, Lin; Zhang, Mingzhi; Huang, Xiaojun |
| 2018 | Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study | Song, Yuqin; Gao, Quanli; Zhang, Huilai; Fan, Lei; Zhou, Jianfeng; Zou, Dehui; Li, Wei; Yang, Haiyan; Liu, Ting; Wang, Quanshun; Lv, Fangfang; Yang, Yu; Guo, Haiyi; Yang, Liudi; Elstrom, Rebecca; Huang, Jane; Novotny, William; Wei, Vivian; Zhu, Jun |
| 2-Feb-2021 | YF-H-2015005, a CXCR4 Antagonist, for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized, Controlled, Phase 3 Clinical Trial | Liu, Weiping; Li, Yufu; Wang, Quanshun; Su, Hang; Ding, Kaiyang; Shuang, Yuerong; Gao, Sujun; Zou, Dehui; Jing, Hongmei; Chai, Ye; Zhang, Yicheng; Liu, Lihong; Wang, Chunling; Liu, Hui; Lin, Jinying; Zhu, Haiyan; Yao, Chen; Yan, Xiaoyan; Shang, Meixia; Wang, Shufang; Chang, Fengyuan; Wang, Xiaopei; Zhu, Jun; Song, Yuqin |
| 20-May-2020 | Zanubrutinib monotherapy for patients with relapsed or refractory non-germinal center diffuse large B-cell lymphoma: Results from a phase II, single-arm, multicenter, study. | Yang, Haiyan; Xiang, Bing; Song, Yuqin; Zhang, Huilai; Zhao, Weili; Zou, Dehui; Lv, Fangfang; Bai, Ou; Liu, Aichun; Li, Caixia; Tan, Ziwen; Wang, Weige; Guo, Haiyi; Novotny, William; Huang, Jane E.; Li, Yufu |
